2022
DOI: 10.3389/fcell.2022.804247
|View full text |Cite
|
Sign up to set email alerts
|

Emerging Roles of Extracellular Vesicle-Delivered Circular RNAs in Atherosclerosis

Abstract: Atherosclerosis (AS) is universally defined as chronic vascular inflammation induced by dyslipidaemia, obesity, hypertension, diabetes and other risk factors. Extracellular vesicles as information transmitters regulate intracellular interactions and their important cargo circular RNAs are involved in the pathological process of AS. In this review, we summarize the current data to elucidate the emerging roles of extracellular vesicle-derived circular RNAs (EV-circRNAs) in AS and the mechanism by which EV-circRN… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 203 publications
0
6
0
Order By: Relevance
“…Hence, infectious agents could induce host cells to release EVs, which, in turn, could provide a long-lasting feedback loop to either exacerbate the infection, local and systemic inflammation, and endothelial dysfunction also at distant sites [ 24 , 39 ], suggesting a mechanistic role of EVs at the intersection of inflammatory processes and CVD [ 24 ]. Coming back to the specific context of hepatitis C, this could be crucial not only as regards the well-known damage of EVs on the liver—primarily due to their role in mediating immune response evasion and progressive fibrosis development—[ 40 , 41 ], but also concerning some of the aforementioned extrahepatic manifestations most linked to atherosclerosis and/or coagulation activation, although this still deserves further confirmation at least in patients with mild to moderate liver disease [ 42 , 43 , 44 ]. Furthermore, this could be an explanation for why the detrimental effect induced by HCV infection can persist over time well after the end of the acute phase or viral eradication [ 19 , 45 ].…”
Section: Discussionmentioning
confidence: 99%
“…Hence, infectious agents could induce host cells to release EVs, which, in turn, could provide a long-lasting feedback loop to either exacerbate the infection, local and systemic inflammation, and endothelial dysfunction also at distant sites [ 24 , 39 ], suggesting a mechanistic role of EVs at the intersection of inflammatory processes and CVD [ 24 ]. Coming back to the specific context of hepatitis C, this could be crucial not only as regards the well-known damage of EVs on the liver—primarily due to their role in mediating immune response evasion and progressive fibrosis development—[ 40 , 41 ], but also concerning some of the aforementioned extrahepatic manifestations most linked to atherosclerosis and/or coagulation activation, although this still deserves further confirmation at least in patients with mild to moderate liver disease [ 42 , 43 , 44 ]. Furthermore, this could be an explanation for why the detrimental effect induced by HCV infection can persist over time well after the end of the acute phase or viral eradication [ 19 , 45 ].…”
Section: Discussionmentioning
confidence: 99%
“…87 CircRNAs derived from extracellular vesicles can also elevate the risk of hypertension and atherosclerosis by modulating blood lipids, lipid deposition, and endothelial cell function. 199 Evidence shows that ncRNAs have significant biological functions and participate in forming complex gene regulatory networks. Exosomes assist in transporting ncRNAs to distant organs, amplifying the negative effects of AT.…”
Section: Circrnas In Obesity-associated Diseasesmentioning
confidence: 99%
“…Mechanistically, circRNAs can competitively bind to miRNAs to regulate the expression of genes associated with coronary artery disease 87 . CircRNAs derived from extracellular vesicles can also elevate the risk of hypertension and atherosclerosis by modulating blood lipids, lipid deposition, and endothelial cell function 199 …”
Section: Ncrnas In Obesity‐associated Diseasesmentioning
confidence: 99%
“…CircRNAs have been identified in the process of AS, such as circ_USP36, circ_0007478, circCHFR, and circ_0001879 ( 219 223 ). CircRNAs encapsulated in EVs were also involved in the process of AS ( 224 ). CircNPHP4 in monocyte-EVs regulated heterogeneous adhesion in coronary heart atherosclerotic disease by the modulation of miR-1231 ( 225 ).…”
Section: The Emerging Role Of Circrnas Encapsulated In Evs In As and ...mentioning
confidence: 99%